Profile data is unavailable for this security.
About the company
Cardinal Health, Inc. is a global healthcare services and products company. The Company is engaged in providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and patients in the home. The Company also provides pharmaceuticals and medical products. The Company’s segments include Pharmaceutical and Specialty Solutions and Global Medical Products and Distribution (GMPD). The Pharmaceutical and Specialty Solutions segment distributes branded and generic pharmaceuticals, specialty pharmaceuticals and over-the-counter healthcare and consumer products in the United States. Its GMPD segment manufactures, sources and distributes Cardinal Health branded medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. The Company connects patients, providers, payers, pharmacists and manufacturers for integrated care coordination.
- Revenue in USD (TTM)222.13bn
- Net income in USD1.56bn
- Incorporated1979
- Employees48.90k
- LocationCardinal Health Inc7000 Cardinal PlDUBLIN 43017United StatesUSA
- Phone+1 (614) 757-3033
- Fax+1 (614) 757-6000
- Websitehttps://www.cardinalhealth.com/en.html
Mergers & acquisitions
| Acquired company | CAH:NYQ since announced | Transaction value |
|---|---|---|
| Texas Digestive Disease Consultants PLLC | 33.52% | 2.80bn |
| North Coast Medical Supply LLC | 33.52% | 1.10bn |
| Integrated Oncology Network LLC | 45.33% | 1.12bn |
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Mar 2025 | 29.56m | 12.24% |
| BlackRock Fund Advisorsas of 31 Mar 2025 | 14.62m | 6.05% |
| SSgA Funds Management, Inc.as of 31 Mar 2025 | 13.04m | 5.40% |
| Geode Capital Management LLCas of 31 Mar 2025 | 6.18m | 2.56% |
| BlackRock Advisors LLCas of 31 Mar 2025 | 5.86m | 2.42% |
| BlackRock Investment Management LLCas of 31 Mar 2025 | 3.30m | 1.37% |
| BlackRock Investment Management (UK) Ltd.as of 31 Mar 2025 | 3.23m | 1.34% |
| Citadel Advisors LLCas of 31 Mar 2025 | 2.74m | 1.14% |
| Invesco Capital Management LLCas of 31 Mar 2025 | 2.59m | 1.07% |
| JPMorgan Investment Management, Inc.as of 31 Mar 2025 | 2.51m | 1.04% |
